The company has received tentative approval from the US Food and Drug Administration (USFDA) for the product which is the generic version of Pfizer's Xeljanz XR tablets, Zydus Cadila said in a statement.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/37pKF6p
via IFTTT
0 comments:
Post a Comment